We did it
From an Idea to a Registrational Pathway for Islet Transplantation This milestone represents the culmination of a remarkable scientific and translational journey that began nearly a decade ago. At NobleCon in 2018, Dr. Camillo Ricordi, as a member of Noble Capital...
Eledon Pharmaceuticals Announces Submission of an Investigational New Drug (IND) Application for Islet Transplantation
Stimulated by the extremely promising preliminary results from our pilot study involving 12 patients, Eledon Pharmaceuticals has submitted an IND application to the U.S. Food and Drug Administration (FDA). This represents the first and a very important step toward...
First 5 Patients with ‘Brittle’ T1D are Insulin-Free
Breaking News from 2025 Congress of Cell Transplantation and Regenerative Medicine Society TOKYO, JAPAN, October 27, 2025 /EINPresswire.com/ -- At the 2025 Congress of the Cell Transplant and Regenerative Medicine Society Saturday, world-renowned expert Dr. Camillo...
First Three Patients with T1D Successfully Transplanted with Novel Antibody to Eliminate Harsh Anti-rejection Drug
Stunning Results of First Human Trials Presented Today in Boston at 5th Summit on Stem Cell Derived Islets MIAMI, FL, UNITED STATES, October 29, 2024 /EINPresswire.com/ — The Cure Alliance, a 501(c)(3) nonprofit, is excited to announce that three patients with type 1...
Founder’s letter to our Cure Alliance friends
Dear Friends, In recent years, The Cure Alliance (TCA) has proudly contributed to clinical trials of stem cell infusions (MSC) in severe COVID-19, and in chronic kidney disease (CKD), providing critically important information on the safety, efficacy, and mechanism of...
The Cure Alliance-funded clinical trial to silence deadliest pancreatic cancer begins recruiting patients today
Miami/September 29, 2023/A phase II clinical trial hoping to silence the deadliest form of pancreatic cancer has started enrolling patients at SUNY Downstate Medical Center in Brooklyn, N.Y., The Cure Alliance announced today. Pancreatic Ductal Adenocarcinoma Cancer...
The Cure Alliance Gets IRB Approval for “C3” Clinical Trial To Treat Deadliest Pancreatic Cancer AT SUNY Downstate
C3," a Combination of 3 Generic Drugs Designed to Halt Advanced Adenocarcinoma Pancreatic Cancer Moves from the Lab to Human Trials MIAMI, FLORIDA, UNITED STATES, July 4, 2023/EINPresswire.com/ -- The Cure Alliance, 501(c)(3) non-profit, announced today State...
Pancreatic Cancer has a New Formidable Foe — A Letter from the President of The Cure Alliance
Eureka. In the FDA’s own library, Dr. F. Charles Brunicardi and his team found a combination of three non-toxic widely used drugs that, when combined, actually turn off tumor-based pancreatic cancer.
Boca Student Pledges Bar Mitzvah Fund To The Cure Alliance
David Hain, 12, of Boca Raton, Florida announced to friends and family he will work to raise funds for The Cure Alliance as part of his year-long community service to commemorate becoming a bar mitzvah. David is a seventh grade gifted student in Loggers' Run Middle...
Watch: Dr. Camillo Ricordi talks about the use of stem cells to treat severely sick COVID-19 patients
Watch this report from 7News Miami as our very own Dr. Camillo Ricordi talks about the use of stem cells in treating those with the most severe cases of COVID-19. Video: 7News Miami